LiveCare Announces Middle East Expansion Initiative Venice, FL, USA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- LiveCare, Inc. OTC:LVCE, a leader in the telehealth sector assisting people living with type II diabetes—often overlooked—become healthier and...

LiveCare Inc. Soars to Over $330,000 In Monthly Billing for May 2022; Continues Explosive Growth Venice, FL USA, June 30, 2022 (GLOBE NEWSWIRE) -- LiveCare Inc. OTC:(LVCE), with its now-proven model of remote patient monitoring, LiveCare Health recorded over $330,000 in monthly gross billing...

After Commencing Trading on OTC Markets, LiveCare Inc. Embarks On Growth Plan Venice, FL USA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- LiveCare Inc. OTC:(LVCE) is poised to take its telehealth services to the next level. Founded in 2018, LiveCare set out to build a remote health...

Endoscopy Devices for Obesity, Type II Diabetes and NASH Market to Garner $3.71 Billion by 2028: AMR Portland, OR, July 08, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Endoscopy Devices for Obesity, Type II Diabetes and Nash Market generate $2.63...